Defence Therapeutics Inc.
DTC
Hisse Senetlerindeki Sıralama
#29536
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Hisse Fiyatı
$0.25964327
Piyasa Değeri
$19.68M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-55.64%
Ülke
CA
Ticaret Defence Therapeutics Inc. (DTC)
Kategori
Healthcare
Defence Therapeutics Inc. (DTC) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.27 - 2026-10-01
Gün sonu en düşük fiyat: $2.50 - 2021-05-01
Gün sonu en düşük fiyat: $2.50 - 2021-05-01
Defence Therapeutics Inc. için hisse fiyatı geçmişi: 2021 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2026 (TTM) | -27.55% |
| 2025 | 58.71% |
| 2024 | -79.59% |
| 2023 | -28.12% |
| 2022 | -37.44% |
| 2021 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $136.67 | -4.47% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
